Switzerland· 48198005
Urokinase 500 000 HS medac, Pulver zur Herstellung einer Injektions-/Infusionslösung
A urokinase product, registered in Switzerland by Regulix GmbH and dispensed under Swissmedic category B. The same ATC class is registered in 6 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Urokinase is registered in 6 of 19 countries.
Countries holding a registration under ATC B01AD04 (urokinase), each read from that country’s own register.
- This record: Switzerland
- 4 of them publish a price we can compare per daily dose
Urokinase · ATC B01AD04
6 / 19 countries
- Belgiumprice
- Finlandprice
- Japan
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
- Manufacturer
- Regulix GmbH
- Country
- Switzerland (CH)
- ATC code
- B01AD04
- ATC class
- Urokinase
- Defined daily dose
- 3 MIO, E
- Swissmedic category
- B
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
130 interactions on record for urokinase.
Graded by severity as the source publishes them — 46 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Urokinase · interactions on record
130 records
- 46 severe
- 84 moderate
Most severe, free to view
- WarfarinB01AA03severe
- HeparinB01AB01severe
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under B01AD04
Urokinase, as other registers publish it.
- FinlandAbbokinaseAbbott France S.A.
- BelgiumActosolv 100000 IUEumedica Pharmaceuticals
- BelgiumActosolv 600000 IUEumedica Pharmaceuticals
- SwitzerlandUrokinase 10 000 HS medac, Pulver zur Herstellung einer Injektions-/InfusionslösungRegulix GmbH
- SwitzerlandUrokinase 100 000 HS medac, Pulver zur Herstellung einer Injektions-/InfusionslösungRegulix GmbH
- SwitzerlandUrokinase 250 000 HS medac, Pulver zur Herstellung einer Injektions-/InfusionslösungRegulix GmbH
- SwitzerlandUrokinase 50 000 HS medac, Pulver zur Herstellung einer Injektions-/InfusionslösungRegulix GmbH
- PolandUrokinase medacPharma-Zentrale GmbH
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0150d08d-6ab9-4a77-8f43-ca7da4ca8ddd GET /v1/drugs/0150d08d-6ab9-4a77-8f43-ca7da4ca8ddd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Biotechnologika"
}See everything about urokinase.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.